The global antithrombin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Antithrombin is defined as a form of protein found in human blood that plays a pivotal role in the stoppage of blood clotting. Antithrombin acts as a natural blood thinner and also finds its application in performing surgical procedures of the patients with low antithrombin levels. Thus, the growing application of antithrombin in various surgical procedures is likely to augment the market growth during the forecast period. Further, the lack of antithrombin may increase the risk of thromboembolism, which can result in extreme bleeding during surgical procedures. Antithrombin III is also used in extracorporeal membrane oxygenation during cardiopulmonary bypass.
To Request a Sample of our Report on Antithrombin Market: https://www.omrglobal.com/request-sample/antithrombin-market
Further, antithrombin can be used for therapeutic purposes in various conditions such as cardiac surgeries, as well as in genetic medical conditions such as antithrombin deficiency. As per the data published by the American Society of Hematology 900,000 people in the US develop blood clots yearly, and they are accountable for approximately 100,000 casualties each year. Furthermore, according to the National Organization for Rare Disorders, every one person in 3,000 to 5,000 people in the US has Type I antithrombin deficiency. The increasing prevalence of blood clotting diseases result in an increased demand for the therapeutic usage of antithrombin. Thus, in these cases, some of the tests such as AT Activity and test of antithrombin antigen level are highly practiced by physicians. Inherited antithrombin deficiency and the acquired deficiency caused by other diseases are two main prominent risk factors for causing antithrombin deficiency.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Application
- By Source
- By Dosage Form
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Grifols, S.A., CSL Ltd., and Takeda Pharmaceutical Co. Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Antithrombin Market is Available @ https://www.omrglobal.com/industry-reports/antithrombin-market
Global Antithrombin Market Report by Segment
By Application
- Therapeutic
- Research
- Diagnostics
By Source
- Human
- Goat Milk
- By Dosage Form
- Lyophilized
- Liquid
Global Antithrombin Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
